The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
An analysis of forty‐two wegener's granulomatosis patients treated with methotrexate and prednisone
Abstract
Objective. To determine the efficacy of low‐dose methotrexate (MTX) plus prednisone in the treatment of Wegener's granulomatosis (WG). Methods. An open‐label study of weekly low‐dose MTX plus prednisone for the treatment of WG was performed. Forty‐two patients who did not have immediately life‐threatening disease were enrolled into the study. Outcome was determined by clinical characteristics and pathologic, laboratory, and radiographic findings. Results. Weekly administration of MTX and prednisone resulted in remission of disease in 30 of the 42 patients (71%). The median time to remission was 4.2 months. The estimated median time to relapse for all patients in whom remission was achieved was 29 months. Eight patients who had relapses were treated with a second course of MTX plus prednisone, and a second remission was induced in 6 of the 8 (75%). Conclusion. Weekly low‐dose MTX was shown in this study to be an acceptable alternative form of therapy for selected patients with WG who do not have immediately life‐threatening disease or who have developed serious cyclophosphamide‐associated toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Wegener Granulomatosis: An Analysis of 158 Patients
Hoffman, G. S., Kerr, G. S., Leavitt, R. Y., Hallahan, C. W., Lebovics, R. S., Travis, W. D., Rottem, M., & Fauci, A. S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-488 · Cited by 2,857
Self-citationFAUCI, A. S., HAYNES, B. F., KATZ, P., & WOLFF, S. M. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-1-76 · Cited by 2,001
Self-citationLeavitt, R. Y., Fauci, A. S., Bloch, D. A., Michel, B. A., Hunder, G. G., Arend, W. P., Calabrese, L. H., Fries, J. F., Lie, J. T., Lightfoot, R. W., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330807 · Cited by 1,947
Self-citationWEGENERʼS GRANULOMATOSIS: STUDIES IN EIGHTEEN PATIENTS AND A REVIEW OF THE LITERATURE
FAUCI, A. S., & WOLFF, S. M. (1973) · Medicine · doi:10.1097/00005792-197311000-00002 · Cited by 788
Self-citationSuccessful Intermittent Chemoprophylaxis for Pneumocystis carinii Pneumonitis
Hughes, W. T., Rivera, G. K., Schell, M. J., Thornton, D., & Lott, L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162604 · Cited by 398
Kerr, G. S., Fleisher, T. A., Hallahan, C. W., Leavitt, R. Y., Fauci, A. S., & Hoffman, G. S. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360312 · Cited by 298
Self-citationSchneider, M. M. E., Hoepelman, A. I. M., Schattenkerk, J. K. M. E., Nielsen, T. L., van der Graaf, Y., Frissen, J. P. H. J., van der Ende, I. M. E., Kolsters, A. F. P., & Borleffs, J. C. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272603 · Cited by 282
Prevention and Treatment of Pneumocystis Pneumonia
Wood, A. J. J., & Masur, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272606 · Cited by 176
Prevention and Treatment of Pneumocystis Pneumonia
(1993) · New England Journal of Medicine · doi:10.1056/nejm199304153281524 · Cited by 169
Methotrexate and trimethoprim-sulphamethoxazole-a potentially hazardous combination
Groenendal, H., & Rampen, F. H. J. (1990) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1990.tb02113.x · Cited by 74
Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole.
Thomas, M., & Gutterman, L. A. (1986) · PubMed · Cited by 72
Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis
Perruquet, J. L., Harrington, T. M., & David, D. E. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780261021 · Cited by 68
Maricic, M. J., Davis, M. D. P., & Gall, E. P. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290118 · Cited by 67
Wollner, A., Mohle‐Boetani, J. C., Lambert, R. E., et al. (1991) · Thorax · doi:10.1136/thx.46.3.205 · Cited by 56
Cornelissen, J. J., Bakker, L. J., van der Veen, M. J., Rozenberg-Arska, M., & Bijlsma, J. W. J. (1991) · Annals of the Rheumatic Diseases · doi:10.1136/ard.50.9.642 · Cited by 43
Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.
Kuitert, L. M. E., & Harrison, A. C. (1991) · Thorax · doi:10.1136/thx.46.12.936 · Cited by 38
Clerc, D., Brousse, C., Mariette, X., Bennet, P., & Bisson, M. (1991) · Annals of the Rheumatic Diseases · doi:10.1136/ard.50.1.67-b · Cited by 35
Cited by
Jennette, J. C., & Falk, R. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372106 · Cited by 1,323
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Yates, M., Watts, R. A., Bajema, I. M., Cid, M. C., Crestani, B., Hauser, T., Hellmich, B., Holle, J. U., Laudien, M., Little, M. A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209133 · Cited by 1,194
EULAR recommendations for the management of primary small and medium vessel vasculitis
Mukhtyar, C., Guillevin, L., Cid, M. C., Dasgupta, B., de Groot, K., Gross, W., Hauser, T., Hellmich, B., Jayne, D., Kallenberg, C. G. M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.088096 · Cited by 990
Kitching, A. R., Anders, H.-J., Basu, N., Brouwer, E., Gordon, J., Jayne, D. R., Kullman, J., Lyons, P. A., Merkel, P. A., Savage, C. O. S., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0204-y · Cited by 928
De Groot, K., Rasmussen, N., Bacon, P. A., Tervaert, J. W. C., Feighery, C., Gregorini, G., Gross, W. L., Luqmani, R., & Jayne, D. R. W. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21142 · Cited by 801
Metadata
- Authors
- Sneller, M. C., Hoffman, G. S., Talar‐Williams, C., Kerr, G. S., Hallahan, C. W., & Fauci, A. S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1995-05
- Volume
- 38
- Issue
- 5
- Pages
- 608-613
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2142627411
- Cited by
- 265
- References
- 19
- FWCI
- 12.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.